Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ACADIA Pharmaceuticals to Present at the Jefferies Life Sciences Conference on June 27, 2006.


SAN DIEGO -- ACADIA Acadia (əkā`dēə), Fr. Acadie, region and former French colony, E Canada, encompassing modern Nova Scotia but also New Brunswick, Prince Edward Island, and coastal areas of E Maine. After an abortive 1604 settlement of St.  Pharmaceuticals Inc. (Nasdaq:ACAD ACAD Academy
ACAD Academic
ACAD AutoCAD (design/drafting development software by Autodesk)
ACAD Acadia National Park (US National Park Service)
ACAD Atherosclerotic Coronary Artery Disease
), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders Nervous system disorders

A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency
, today announced that it will present at the Jefferies Life Sciences Conference on Tuesday, June 27, 2006, at 10:45 a.m. Eastern Time at the Mandarin Oriental Hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
.

A live webcast of ACADIA's presentation will be accessible on the company's website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through July 11, 2006.

About ACADIA Pharmaceuticals

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA currently has five Phase II-stage clinical programs as well as a portfolio of preclinical and discovery assets directed at large unmet medical needs, including schizophrenia, Parkinson's disease, sleep maintenance insomnia, and neuropathic pain. All of the drug candidates in ACADIA's product pipeline emanate from discoveries made using its proprietary drug discovery platform. ACADIA's corporate headquarters is located in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
 and it maintains research and development operations in both San Diego and Malmo, Sweden.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 20, 2006
Words:197
Previous Article:NETSHARE(R) Forges Alliance With Ecademy to Help Executives Build Their Online Brand; NETSHARE Subscribers Now Get Free Membership in World's Largest...
Next Article:CREDO Updates Drilling Activities; Second High-Rate Well Drilled on Glacier Prospect in Northwest Oklahoma; South Texas and Kansas Exploration...
Topics:



Related Articles
Revivals, Baptists and George Rawlyk: a Memorial Volume.
SFBC International to Present at the Jefferies Life Sciences Conference on Wednesday, June 28, 2006; Webcast of Presentation Will Be Available at...
ACADIA Pharmaceuticals to Announce Second Quarter 2006 Financial Results on August 8, 2006; ACADIA to Host Conference Call and Webcast on Tuesday,...
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences.
ACADIA Pharmaceuticals Reports Second Quarter 2006 Financial Results.
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences.
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences.
ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 13, 2007.
Collaborative events in Toronto. (Forum Focus: Collaborative Performance.
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles